Luna Innovations Reports Third-Quarter 2021 Results
Highlights
The following highlights reflect the reclassification of Luna Labs to discontinued operations:
- Total revenues of $20.3 million for the three months ended September 30, 2021, up 32% compared to the three months ended September 30, 2020
- Gross margin of 62% for the three months ended September 30, 2021, compared to 63% for the three months ended September 30, 2020
- Operating loss of $10 thousand for the three months ended September 30, 2021, compared to operating income of $1.2 million for the three months ended September 30, 2020
- Net income of $0.4 million for the three months ended September 30, 2021, compared to net income of $3.1 million for the three months ended September 30, 2020
- Adjusted EBITDA of $2.1 million for the three months ended September 30, 2021, compared to $3.1 million for the three months ended September 30, 2020
- Adjusted EPS of $0.03 for the three months ended September 30, 2021, compared to $0.11 for the three months ended September 30, 2020
(ROANOKE, VA, November 15, 2021) - Luna Innovations Incorporated (NASDAQ: LUNA), a global leader in advanced optical technology, today announced its financial results for the three and nine months ended September 30, 2021.
"Q3 was a record quarter for customer demand of our products, as we realized the highest level of bookings we've ever had," said Scott Graeff, President and Chief Executive Officer of Luna. "The largest backlog in our history is the result of record bookings, the increased impact of COVID and industry-wide supply chain challenges which have slowed our ability to deliver products. As a result, revenue for the year will be lighter than what we could have delivered. We believe that this is a temporary situation and remain committed to Luna's strategy. We continue to see vast opportunities for Luna in fiber optic technologies and are pleased to take the pivotal step in focusing on fiber with our transition of Luna Labs to discontinued operations. We have evaluated a number of opportunities and look forward to sharing Luna's meaningful achievements over the coming months."
Third-Quarter Fiscal 2021 Financial Summary
Highlights of the financial results for the three months ended September 30, 2021 are:
|
|
|
|
Three Months Ended September 30, |
|
Change |
||||||||
|
(in thousands, except share and per share data) |
|
2021 |
|
2020 |
|
|
|||||||
|
Revenues |
|
$ |
20,329 |
|
|
$ |
15,350 |
|
|
32 |
|
% |
|
|
|
|
|
|
|
|
|
|
||||||
|
Gross profit |
|
12,584 |
|
|
9,632 |
|
|
31 |
|
% |
|||
|
Gross margin |
|
62 |
% |
|
63 |
% |
|
|
|||||
|
|
|
|
|
|
|
|
|||||||
|
Operating expense |
|
12,594 |
|
|
8,420 |
|
|
50 |
|
% |
|||
|
Operating (loss)/income |
|
(10) |
|
|
1,212 |
|
|
|
|
||||
|
Operating margin |
|
— |
% |
|
8 |
% |
|
|
|
||||
|
|
|
|
|
|
|
|
|||||||
|
Other (expense)/income and income tax benefit/(expense) |
|
(334) |
|
|
1,096 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||
|
Net (loss)/income from continuing operations |
|
$ |
(344) |
|
|
$ |
2,308 |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
Income from discontinued operations, net of income tax of $235 and $247 |
|
699 |
|
|
794 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||
|
Net income |
|
$ |
355 |
|
|
$ |
3,102 |
|
|
(89) |
|
% |
|
|
|
|
|
|
|
|
|
|
||||||
|
Earnings per diluted share (EPS) |
|
$ |
0.01 |
|
|
$ |
0.10 |
|
|
(90) |
|
% |
|
|
Adjusted EPS |
|
$ |
0.03 |
|
|
$ |
0.11 |
|
|
(73) |
|
% |
|
|
Diluted weighted average shares outstanding |
|
33,780,714 |
|
|
32,411,086 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Adjusted EBITDA |
|
$ |
2,110 |
|
|
$ |
3,144 |
|
|
(33) |
|
% |
|
A reconciliation of Adjusted EPS and Adjusted EBITDA to the nearest comparable figures under generally accepted accounting principles ("GAAP") can be found in the schedules included in this release.
Revenues for the three months ended September 30, 2021 increased compared to the prior-year period, primarily due to revenue generated by the businesses we have recently acquired over the last year.
Gross margin decreased to 62% for the three months ended September 30, 2021, compared to 63% for the three months ended September 30, 2020, driven primarily by product mix. Operating loss and margin declined to $10 thousand and less than 1% of total revenues, respectively, for the three months ended September 30, 2021, compared to $1.2 million and 8% of total revenues, respectively, for the three months ended September 30, 2020. The decrease in operating income was primarily due to an increase in operating expenses and amortization related to our recent acquisitions.
Net income was $0.4 million, or $0.01 per fully diluted share, for the three months ended September 30, 2021, compared to net income of $3.1 million, or $0.10 per fully diluted share, for the three months ended September 30, 2020. Adjusted EPS was $0.03 for the three months ended September 30, 2021 compared to $0.11 for the three months ended September 30, 2020.
Adjusted EBITDA was $2.1 million for three months ended September 30, 2021, compared to $3.1 million for the three months ended September 30, 2020. The decrease was driven by lower income from continuing operations.
Nine Months Ended Fiscal 2021 Financial Summary
Highlights of the financial results for the nine months ended September 30, 2021 are:
|
|
|
|
Nine months ended September 30, |
|
Change |
||||||||
|
(in thousands, except share and per share data) |
|
2021 |
|
2020 |
|
|
|||||||
|
Revenues |
|
$ |
63,291 |
|
|
$ |
39,837 |
|
|
59 |
|
% |
|
|
|
|
|
|
|
|
|
|
||||||
|
Gross profit |
|
37,436 |
|
|
24,126 |
|
|
55 |
|
% |
|||
|
Gross margin |
|
59 |
% |
|
61 |
% |
|
|
|||||
|
|
|
|
|
|
|
|
|||||||
|
Operating expense |
|
41,061 |
|
|
23,252 |
|
|
77 |
|
% |
|||
|
Operating (loss)/income |
|
(3,625) |
|
|
874 |
|
|
|
|
||||
|
Operating margin |
|
(6) |
% |
|
2 |
% |
|
|
|
||||
|
|
|
|
|
|
|
|
|||||||
|
Other (expense)/income and income tax benefit/(expense) |
|
1,061 |
|
|
1,012 |
|
|
5 |
|
% |
|||
|
|
|
|
|
|
|
|
|
||||||
|
Net (loss)/income from continuing operations |
|
$ |
(2,564) |
|
|
$ |
1,886 |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
Income from discontinued operations, net of income tax of $381 and $209 |
|
2,371 |
|
|
1,469 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||
|
Net (loss)/income |
|
$ |
(193) |
|
|
$ |
3,355 |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
Earnings per diluted share (EPS) |
|
$ |
(0.01) |
|
|
$ |
0.10 |
|
|
|
|
||
|
Adjusted EPS |
|
$ |
0.08 |
|
|
$ |
0.14 |
|
|
(43) |
|
% |
|
|
Diluted weighted average shares outstanding |
|
33,585,973 |
|
|
32,478,625 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Adjusted EBITDA |
|
$ |
4,461 |
|
|
$ |
4,990 |
|
|
(11) |
|
% |
|
A reconciliation of Adjusted EPS and Adjusted EBITDA to the nearest comparable GAAP figures can be found in the schedules included in this release.
Revenues for the nine months ended September 30, 2021 increased compared to the prior-year period, primarily due to our recent acquisitions.
Gross margin of 59% for the nine months ended September 30, 2021 was down compared to 61% for the nine months ended September 30, 2020 due to product mix. Operating loss and margin declined to $3.6 million and (6)% of total revenues, respectively, for the nine months ended September 30, 2021, compared to $0.9 million and 2% of total revenues, respectively, for the nine months ended September 30, 2020. The decrease in operating income was primarily due to $2.1 million of integration and transaction costs, as well as $1.6 million of amortization of intangible assets and inventory step-up related to Luna's recently completed acquisitions and its continuing portfolio activities.
Net loss was $0.2 million, or $(0.01) per fully diluted share, for the nine months ended September 30, 2021, compared to a net income of $3.4 million, or $0.10 per fully diluted share, for the nine months ended September 30, 2020. Adjusted EPS was $0.08 for the nine months ended September 30, 2021, compared to $0.14 for the nine months ended September 30, 2020.
Adjusted EBITDA was $4.5 million for the nine months ended September 30, 2021, compared to $5.0 million for the nine months ended September 30, 2020.
2021 Full-Year Outlook
Luna is revising guidance to reflect the reclassification of Luna Labs to discontinued operations and COVID-19 pandemic related issues:
- Total revenue of $85 million to $88 million
- Adjusted EBITDA of $6 million to $8 million
Adjusted EBITDA is a non-GAAP measure. Luna is not providing an outlook for net income/(loss), which is the most directly comparable GAAP measure to Adjusted EBITDA, because changes in the items that Luna excludes from net income to calculate Adjusted EBITDA, such as share-based compensation, tax expense, and significant non-recurring charges, among other things, can be dependent on future events that are less capable of being controlled or reliably predicted by management and are not part of Luna's routine operating activities.
The outlook above does not include any future acquisitions, divestitures, or unanticipated events.
Non-GAAP Financial Measures
In evaluating the operating performance of its business, Luna’s management considers Adjusted EBITDA and Adjusted EPS, which exclude certain charges and income that are required by GAAP. Adjusted EBITDA and Adjusted EPS provide useful information to both management and investors by excluding the effect of certain non-cash expenses and items that Luna believes may not be indicative of its operating performance, because either they are unusual and Luna does not expect them to recur in the ordinary course of its business, or they are unrelated to the ongoing operation of the business in the ordinary course. Adjusted EBITDA and Adjusted EPS should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. Adjusted EBITDA and Adjusted EPS have been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.
Conference Call Information
As previously announced, Luna will conduct an investor conference call at 5:00 pm (ET) today to discuss its financial results for the three and nine months ended September 30, 2021. The investor conference call will be available via live webcast on the Luna website at www.lunainc.com under the tab “Investor Relations.” To participate by telephone, the domestic dial-in number is 844.578.9643 and the international dial-in number is 270.823.1522. The participant access code is 6088397. Investors are advised to dial in at least five minutes prior to the call to register. The webcast will be archived on the company’s website under “Webcasts and Presentations” for 30 days following the conference call.
About Luna
Luna Innovations Incorporated (www.lunainc.com) is a leader in optical technology, providing unique capabilities in high-performance, fiber optic-based, test products for the telecommunications industry and distributed fiber optic-based sensing for a multitude of industries. Luna’s business model is designed to accelerate the process of bringing new and innovative technologies to market.
Forward-Looking Statements
The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include Luna's expectations regarding its projected 2021 financial results and outlook, the Company's growth potential, the resolution of backlog and supply chain challenges and the potential sale of Luna Labs. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of Luna may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation, failure of demand for Luna's products and services to meet expectations, failure of target market to grow and expand, technological and strategic challenges, uncertainties related to the ultimate impact of the COVID-19 pandemic and those risks and uncertainties set forth in Luna’s Form 10-Q for the quarter ended September 30, 2021, and Luna's other periodic reports and filings with the Securities and Exchange Commission ("SEC"). Such filings are available on the SEC’s website at www.sec.gov and on Luna’s website at www.lunainc.com. The statements made in this release are based on information available to Luna as of the date of this release and Luna undertakes no obligation to update any of the forward-looking statements after the date of this release.
To view the full release please click here.
Investor Contact:
Allison Woody
Phone: 540-769-8465
Email: [email protected]